<p>Claudin gene expression profiles and clinical value in colorectal tumors classified according to their molecular subtype</p>

Abstract

This analysis of <i>CLDN</i> gene expression profiles and prognostic value in CRC samples classified according to their molecular subtype shows that CRC heterogeneity must be taken into account when assessing <i>CLDN</i> potential value as prognostic markers or therapeutic targets.